Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 21, Issue 9, Pages 1309-1322
Publisher
Informa Healthcare
Online
2012-07-11
DOI
10.1517/13543784.2012.704019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2-Arachidonoylglycerol Signaling in Forebrain Regulates Systemic Energy Metabolism
- (2012) Kwang-Mook Jung et al. Cell Metabolism
- Hepatic Cannabinoid Receptor-1 Mediates Diet-Induced Insulin Resistance via Inhibition of Insulin Signaling and Clearance in Mice
- (2012) Jie Liu et al. GASTROENTEROLOGY
- Design and Synthesis of Cannabinoid Receptor 1 Antagonists for Peripheral Selectivity
- (2012) Alan Fulp et al. JOURNAL OF MEDICINAL CHEMISTRY
- Dietary Linoleic Acid Elevates Endogenous 2-AG and Anandamide and Induces Obesity
- (2012) Anita R. Alvheim et al. Obesity
- Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity
- (2011) Alan Fulp et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Anti-obesity efficacy of LH-21, a cannabinoid CB1 receptor antagonist with poor brain penetration, in diet-induced obese rats
- (2011) Mónica Alonso et al. BRITISH JOURNAL OF PHARMACOLOGY
- Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis
- (2011) J. D. O'Hare et al. DIABETES
- Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations - a comparative bioavailability study of fish oil vs. krill oil
- (2011) Jan Schuchardt et al. Lipids in Health and Disease
- Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects
- (2011) Sebastiano Banni et al. Nutrition & Metabolism
- Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice
- (2011) Fabiana Piscitelli et al. Nutrition & Metabolism
- Endocannabinoid signal in the gut controls dietary fat intake
- (2011) N. V. DiPatrizio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Moderate doses of EPA and DHA from re-esterified triacylglycerols but not from ethyl-esters lower fasting serum triacylglycerols in statin-treated dyslipidemic subjects: Results from a six month randomized controlled trial
- (2011) J.P. Schuchardt et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats
- (2011) Torbjörn U. C. Järbe et al. PSYCHOPHARMACOLOGY
- Peripheral effects of the endocannabinoid system in energy homeostasis: Adipose tissue, liver and skeletal muscle
- (2011) Cristoforo Silvestri et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Rational design of a novel peripherally-restricted, orally active CB1 cannabinoid antagonist containing a 2,3-diarylpyrrole motif
- (2010) Laurent Hortala et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation
- (2010) R Makwana et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats
- (2010) CL Limebeer et al. BRITISH JOURNAL OF PHARMACOLOGY
- A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents
- (2010) NL Cluny et al. BRITISH JOURNAL OF PHARMACOLOGY
- CB1 Signaling in Forebrain and Sympathetic Neurons Is a Key Determinant of Endocannabinoid Actions on Energy Balance
- (2010) Carmelo Quarta et al. Cell Metabolism
- Discovery of 1-(2,4-Dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a Potential Peripheral Cannabinoid-1 Receptor Inverse Agonist
- (2010) Ming-Shiu Hung et al. ChemMedChem
- Cannabinoid Receptor Stimulation Impairs Mitochondrial Biogenesis in Mouse White Adipose Tissue, Muscle, and Liver: The Role of eNOS, p38 MAPK, and AMPK Pathways
- (2010) L. Tedesco et al. DIABETES
- CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
- (2010) T. Jourdan et al. DIABETES
- Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle
- (2010) K. A. Lindborg et al. DIABETES OBESITY & METABOLISM
- Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age
- (2010) J. Agudo et al. DIABETOLOGIA
- Ligand binding sensitivity of the extracellular loop two of the cannabinoid receptor 1
- (2010) Alexander C. Bertalovitz et al. DRUG DEVELOPMENT RESEARCH
- How inverse can a neutral antagonist be? Strategic questions after the rimonabant issue
- (2010) Jesús Giraldo DRUG DISCOVERY TODAY
- Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB1 receptor antagonist
- (2010) Jenny L. Wiley et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Prevalence and Trends in Obesity Among US Adults, 1999-2008
- (2010) Katherine M. Flegal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pathogenesis of Insulin Resistance in Skeletal Muscle
- (2010) Muhammad A. Abdul-Ghani et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity
- (2010) Joseph Tam et al. JOURNAL OF CLINICAL INVESTIGATION
- The Cannabinoid 1–Receptor Silent Antagonist O-2050 Attenuates Preference for High-Fat Diet and Activated Astrocytes in Mice
- (2010) Sei Higuchi et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Biphasic suppression of appetite by cannabinoid CB1 receptor antagonists with distinct functional activities
- (2010) Yinchiu Lin et al. PHARMACOLOGICAL RESEARCH
- The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in rats
- (2010) K.S. Sink et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behavior
- (2010) P.A. Randall et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The neutral cannabinoid CB1 receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat
- (2010) Nina L. Cluny et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial function in rats fed a high-fat diet
- (2009) Mélissa Flamment et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Delta(9)-tetrahydrocannabinol Enhances an Increase of Plasma Corticosterone Levels Induced by Forced Swim-Stress
- (2009) Kazunori Sano et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Novel thioamide derivatives as neutral CB1 receptor antagonists
- (2009) Jonas Boström et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood–brain-barrier
- (2009) Jean-Marie Receveur et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and Pharmacological Activity of a Potent Inhibitor of the Biosynthesis of the Endocannabinoid 2-Arachidonoylglycerol
- (2009) Tiziana Bisogno et al. ChemMedChem
- Regulation of MAP Kinase-Directed Mitogenic and Protein Kinase B-Mediated Signaling by Cannabinoid Receptor Type 1 in Skeletal Muscle Cells
- (2009) C. Lipina et al. DIABETES
- Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: Comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142
- (2009) K.S. Sink et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats
- (2009) Vincenzo Di Marzo et al. INTERNATIONAL DAIRY JOURNAL
- Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control
- (2009) M-H Son et al. INTERNATIONAL JOURNAL OF OBESITY
- Endocannabinoids May Mediate the Ability of (n-3) Fatty Acids to Reduce Ectopic Fat and Inflammatory Mediators in Obese Zucker Rats
- (2009) Barbara Batetta et al. JOURNAL OF NUTRITION
- Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans
- (2009) Marica Bordicchia et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis
- (2009) Vanessa Deveaux et al. PLoS One
- Effect of Rimonabant on the High-Triglyceride/ Low–HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat
- (2008) Jean-Pierre Després et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Synthesis and characterization of a peripherally restricted CB1 cannabinoid antagonist, URB447, that reduces feeding and body-weight gain in mice
- (2008) Jesse LoVerme et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Paracrine Activation of Hepatic CB1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver
- (2008) Won-il Jeong et al. Cell Metabolism
- Cannabinoid Type 1 Receptor Blockade Promotes Mitochondrial Biogenesis Through Endothelial Nitric Oxide Synthase Expression in White Adipocytes
- (2008) L. Tedesco et al. DIABETES
- Peripheral, but Not Central, CB1 Antagonism Provides Food Intake-Independent Metabolic Benefits in Diet-Induced Obese Rats
- (2008) R. Nogueiras et al. DIABETES
- Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors
- (2008) V. Di Marzo et al. DIABETOLOGIA
- Adipose tissue dysfunction in obesity, diabetes, and vascular diseases
- (2008) G. R. Hajer et al. EUROPEAN HEART JOURNAL
- Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor
- (2008) Richard Z. Chen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
- (2008) Douglas Osei-Hyiaman et al. JOURNAL OF CLINICAL INVESTIGATION
- Bioisosteric Replacement of the Pyrazole 5-Aryl Moiety ofN-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A). A Novel Series of Alkynylthiophenes as Potent and Selective Cannabinoid-1 Receptor Antagonists
- (2008) Shi-Liang Tseng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Central Versus Peripheral Antagonism of Cannabinoid CB1 Receptor in Obesity: Effects of LH-21, a Peripherally Acting Neutral Cannabinoid Receptor Antagonist, in Zucker Rats
- (2008) F. J. Pavón et al. JOURNAL OF NEUROENDOCRINOLOGY
- Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets
- (2008) Isabel Matias et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The Cannabinoid CB1 Receptor Antagonist Rimonabant Stimulates 2-Deoxyglucose Uptake in Skeletal Muscle Cells by Regulating the Expression of Phosphatidylinositol-3-kinase
- (2008) I. Esposito et al. MOLECULAR PHARMACOLOGY
- Leptin controls adipose tissue lipogenesis via central, STAT3–independent mechanisms
- (2008) Christoph Buettner et al. NATURE MEDICINE
- Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: Effects on food-reinforced behavior and comparisons with AM4113
- (2008) K.S. Sink et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins
- (2008) M. A. Ruby et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes
- (2007) I MATIAS BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now